Average Co-Inventor Count = 5.87
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hydra Biosciences, Inc. (16 from 49 patents)
2. Cadent Therapeutics, Inc. (6 from 17 patents)
3. Novartis Ag (4 from 3,923 patents)
4. Other (1 from 832,680 patents)
5. Eli Lilly and Company (1 from 4,442 patents)
6. Yale University (1 from 1,325 patents)
29 patents:
1. 12414927 - CXCR5 antagonists and methods of treating diseases or disorders using same
2. 12358929 - NMDA receptor modulators and uses thereof
3. 12162890 - Heteroaromatic NMDA receptor modulators and uses thereof
4. 11807650 - NMDA receptor modulators and uses thereof
5. 11648253 - Thienopyrimidinone NMDA receptor modulators and uses thereof
6. 11541057 - Thienopyrimidinone NMDA receptor modulators and uses thereof
7. 11274107 - NMDA receptor modulators and uses thereof
8. 11236104 - Heteroaromatic NMDA receptor modulators and uses thereof
9. 10973825 - Thienopyrimidinone NMDA receptor modulators and uses thereof
10. 10626122 - Heteroaromatic NMDA receptor modulators and uses thereof
11. 10500205 - Thienopyrimidinone NMDA receptor modulators and uses thereof
12. 10351567 - Methods and compositions for treating pain
13. 9895356 - Methods and compositions for treating anxiety
14. 9815838 - Methods and compositions for treating pain
15. 9486455 - Compounds for modulating TRPV3 function